Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population

ConclusionNAFLD is associated with a number of EHMs that increases its mortality and increased healthcare expenditure.

http://link.springer.com/10.1007/s12072-020-10038-w

Source: Hepatology International - April 15, 2020 Category: Infectious Diseases Source Type: research

More News: Alcoholism | Brain | Cancer | Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Cirrhosis | Dementia | Depression | Diabetes | Endocrinology | Fatty Liver Disease (FLD) | Heart | Hepatocellular Carcinoma | Hypertension | Infectious Diseases | Liver | Liver Cancer | Liver Disease | Medicare | Neurology | Non-alcoholic Fatty Liver Diseases (NAFLD) | Renal Failure | Thyroid | Thyroid Cancer | Urology & Nephrology